Skip to main content
6-Sulfatoxymelatonin · Normal: 8-56 ug/24hr · Optimal: 15-40 ug/24hr

What Is Melatonin 6 Sulfatoxymelatonin? Normal vs Optimal Range Explained

6-Sulfatoxymelatonin (aMT6s) is the primary urinary metabolite of melatonin, giving the most accurate picture of your overnight melatonin production. Lab ranges vary widely (roughly 8–56 ug/24hr by age), but optimal sleep-supporting production falls between 15–40 ug/24hr. Low values indicate impaired serotonin-to-melatonin conversion, blue light disruption, or medication-induced suppression.

Want to check YOUR levels? Upload labs freeFree, 10 seconds →

Data sourced from CTD, ChEMBL, PubMed. How we verify this data →
Sources verified as of April 2026
[01]

Normal vs Optimal Range

Lab Normal Range: 856 ug/24hr
Optimal: 1540 ug/24hr
8 ug/24hr56 ug/24hr
Lab NormalOptimal

Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.

Range TypeLowHighUnit
Lab Normal856ug/24hr
Optimal1540ug/24hr
[02]

Why Optimal Matters

Laboratory reference ranges for 6-sulfatoxymelatonin vary enormously—from as low as 8 ug/24hr in older adults to above 56 ug/24hr in young adults—because melatonin production naturally declines with age. But this age-adjusted acceptance obscures the fact that melatonin serves functions far beyond sleep initiation. The CTD maps over 1,600 gene–chemical interactions for melatonin and its metabolites, confirming roles in antioxidant defense, immune regulation, DNA repair during sleep, and circadian coordination of hormone release. When 6-sulfatoxymelatonin drops below 15 ug/24hr at any age, these protective functions are compromised. The serotonin-to-melatonin conversion pathway requires two sequential enzymes—AANAT and ASMT—plus adequate serotonin substrate, tryptophan supply, and darkness signaling through the suprachiasmatic nucleus. A low 6-sulfatoxymelatonin result could reflect a problem at any of these steps.

Beta-blockers are one of the most underappreciated suppressors of melatonin production. These widely prescribed cardiovascular medications block the beta-1 adrenergic receptors on the pineal gland that trigger nighttime melatonin release, often reducing production by 50–80%. The ChEMBL database catalogs binding affinity data for over 340 beta-adrenergic compounds, documenting the direct receptor antagonism that explains why insomnia is such a common beta-blocker side effect. Propranolol, atenolol, and metoprolol are the worst offenders because they cross the blood-brain barrier and reach the pineal gland at therapeutic doses. Patients who develop sleep problems after starting a beta-blocker should have 6-sulfatoxymelatonin tested—the result will often confirm the medication as the cause and justify melatonin replacement therapy.

Targeting the 15–40 ug/24hr optimal window supports not only sleep architecture but also the nightly antioxidant and immune housekeeping that occurs during deep sleep phases. PubMed indexes over 9,200 publications on melatonin's role in human health beyond sleep, including its function as a direct free radical scavenger that penetrates mitochondria—a compartment most dietary antioxidants cannot reach. Blue light exposure after sunset is the single most modifiable factor suppressing melatonin production in modern life, because short-wavelength light directly inhibits the pineal gland's melatonin release through the retinohypothalamic tract. Testing 6-sulfatoxymelatonin gives a concrete number to what most people only experience subjectively as poor sleep, turning vague complaints into a measurable, treatable deficiency.

Want to see where YOUR levels fall?

Upload labs free — instant results →
[03]

Symptoms When Low

Difficulty falling asleep at a consistent bedtime despite feeling tiredFrequent nighttime awakenings with difficulty returning to sleepNon-restorative sleep—waking up feeling unrefreshed despite adequate hoursIncreased daytime anxiety or agitation, especially in the eveningReduced immunity and increased susceptibility to infectionsWorsening mood or seasonal depression during shorter daylight months
[04]

Symptoms When High

Excessive daytime sleepiness and difficulty maintaining alertnessProlonged sleep duration beyond typical needs with persistent grogginessMorning headaches and difficulty waking at the intended time
[05]

What Affects This Marker

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD). Over 1,600 gene–chemical interactions mapped for melatonin and its metabolites. North Carolina State University, 2025.
  2. [2]ChEMBL. Binding affinity data cataloged for over 340 beta-adrenergic receptor compounds. European Bioinformatics Institute, 2025.
  3. [3]PubMed. Over 9,200 indexed publications on melatonin's role in human health beyond sleep. National Library of Medicine.
  4. [4]Scheer FA, Morris CJ, Garcia JI, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers. Sleep. 2012;35(10):1395-1402. PMID: 23024438.
  5. [5]Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. 2015;61(2-3):77-84. PMID: 25908646.
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Upload Your Lab Results

See where your levels fall on the optimal scale.

Upload Labs Free →